<DOC>
	<DOCNO>NCT00735020</DOCNO>
	<brief_summary>This trial design evaluate safety , tolerability immunogenicity bedside mix formulation adjuvanted influenza vaccine .</brief_summary>
	<brief_title>Study Evaluate Safety , Tolerability Immunogenicity Bedside Mixing Combination Two Adjuvanted Influenza Vaccines</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy 18 39 year old male females good health provide informed consent prior enrollment serious medical condition allergy vaccine component , include limited egg/chicken product reduce immune function recent use immunosuppressive therapy recent use influenza vaccine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>influenza</keyword>
	<keyword>vaccine</keyword>
	<keyword>adjuvant</keyword>
	<keyword>flu</keyword>
</DOC>